Directory
>
Shijie Tang
Shijie Tang
Vice President, Data Sciences | Karyopharm Therapeutics Inc.
Cambridge, Massachusetts, United States
Shijie Tang
Summary
Shijie Tang is a seasoned executive with extensive experience in data sciences and biostatistics within the pharmaceutical industry. Currently serving as the Vice President of Data Sciences at Karyopharm Therapeutics, he leads multiple functions including biostatistics, data science, and statistical programming. His career spans over a decade in various leadership roles at notable companies such as Ariad Pharmaceuticals and Bristol Myers Squibb. Shijie's academic background includes a Ph.D. in Statistics from the University of Wisconsin-Madison, showcasing his strong analytical skills. He has a proven track record of driving data-driven decision-making processes in clinical development. Beyond his professional pursuits, he also contributes to the community as an assistant soccer coach. His diverse experiences reflect a blend of technical expertise and leadership acumen in the biotech field.
Shijie Tang
Work Experience
Vice President, Data Sciences at
Karyopharm Therapeutics Inc.
January 2020 - Present
Executive Director, Head of Biostatistics at
Karyopharm Therapeutics Inc.
April 2018 - December 2019
Assistant Soccer Coach at
Belmont Second Soccer
September 2017 - December 2018
Senior Director, Biostatistics at
Karyopharm Therapeutics Inc.
March 2017 - April 2018
Associate Director at
Takeda Pharmaceuticals America, Inc.
July 2016 - March 2017
Associate Director at
Infinity Pharmaceuticals
February 2014 - July 2016
Principal Biostatistician at
Takeda Oncology
December 2012 - February 2014
Principal Biostatistician at
Boehringer Ingelheim
April 2011 - December 2012
Sr. Research Biostatistician at
Bristol Myers Squibb
October 2007 - April 2011
Shijie Tang
Education
University of Wisconsin-Madison, Doctor Of Philosophy (Ph.D.)
January 2002 - January 2007
University of Science and Technology of China, B.S
January 1997 - January 2002
Frequently Asked Questions about Shijie Tang
What is Shijie Tang email address?
Shijie Tang's primary email address is *****@karyopharm.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Shijie Tang work for?
Shijie Tang is a Vice President, Data Sciences at Karyopharm Therapeutics Inc., a company specializing in Biological products, except diagnostic.
Where Shijie Tang graduated from?
Shijie Tang holds a degree in Statistics from University of Wisconsin-Madison.
How can I directly contact Shijie Tang?
To contact Shijie Tang directly, you can use the email address *****@karyopharm.com. Complete contact information is available upon registration with Muraena.
Is Shijie Tang an immigrant?
Yes, Shijie Tang is an immigrant and currently based in United States
Who is Shijie Tang?
Shijie Tang is a seasoned executive with extensive experience in data sciences and biostatistics within the pharmaceutical industry. Currently serving as the Vice President of Data Sciences at Karyopharm Therapeutics, he leads multiple functions including biostatistics, data science, and statistical programming. His career spans over a decade in various leadership roles at notable companies such as Ariad Pharmaceuticals and Bristol Myers Squibb. Shijie's academic background includes a Ph.D. in Statistics from the University of Wisconsin-Madison, showcasing his strong analytical skills. He has a proven track record of driving data-driven decision-making processes in clinical development. Beyond his professional pursuits, he also contributes to the community as an assistant soccer coach. His diverse experiences reflect a blend of technical expertise and leadership acumen in the biotech field.
Shijie`s contact details
*****@karyopharm.com
Colleagues
Independent Board Director
Lecturer, Graduate Program (Regulatory Affairs)
Vice President Research & Translational Medicine
Vice President, Business Operations and Corporate Affairs
Executive Director - Head of Medical Strategy Global Medical and Scientific Affairs
Vice President of Market Access
Vice President, Clinical Pharmacology
Vice President, Program Lead - Oncology
Vice President, Clinical Development - Myelofibrosis and MDS
Vice President, Regulatory Affairs